Generic Drug Reforms: FTC Notification Bill Appears Ready To Move In 2003
This article was originally published in The Tan Sheet
Executive Summary
A bill to require reporting of brand/generic patent settlements to the Federal Trade Commission appears ready to move early in the 108th Congress